Page 3«..2345..1020..»

transhumanism Biblical Life Assembly

The Shinar DirectivePart 2

Posted on December 7, 2014

Published: December 07, 2014

by Dr. Michael Lake

In chapter two of The Shinar Directive, we uncover a gold mine of information encoded into the stories presented in the Torah (especially in the book of Genesis). The sages of Israel understood these hidden mysteries and taught that it would take a faithful student of the Word a lifetime just to discover some of the secrets God presented to us in Genesis 13.

Over the years, several of my students have attempted to develop an exhaustive study of the book of Genesis for their doctoral dissertations. As they examined the original language of the Hebrew text and discovered such a treasure trove of information, they concluded that their dissertations could only cover a fraction of what is available in just the first chapter. Even then, many of their papers far surpassed the required standard length of a doctoral dissertation. What God can say in one sentence can become a lifetime of study for any serious student of the Word.

The perfect example of the power of one sentence from God is when Jesus made a seemingly simple statement in Matthew 24:37:

But as the days of Noe were, so shall also the coming of the Son of man be. (Matthew 24:37)

Jesus was speaking of the last days. In the verse that preceded this statement, we find:

But of that day and hour knoweth no man, no, not the angels of heaven, but my Father only. (Matthew 24:36)

Since we have been so deprived of our Hebraic heritage, most students of the Bible miss the fact that Jesus had just used a Hebraic idiom that connected what He was sharing with the Feast of Trumpets. The language He continued to use in verses 4042 confirms this fact for those who use the tools of hermeneutical[i] research to understand the cultural setting in which Jesus taught. Although the purpose of this chapter is not to teach on the importance of cultural idioms[ii] and their proper use within our exegetical[iii] exercises to glean truth from the Word of God, I hope I have sparked your interest enough to promote expansion of your hermeneutical toolbox. We need to realize that Jesus did not minister in the streets of Detroit or the country hills of Kentucky. He spoke to a culture that had a deep and enriched heritage cultivated by the God of Abraham, Isaac, and Jacob and nourished by a study of Torah. Biblical scholar Dr. John Garr makes this observation regarding our habitual dismissal of the cultural setting in our interpretative processes:

The problem is that practically all societies and people groups have read their own concepts and cultures into the Bible rather than drawing out of the Holy Scriptures the truths that have always been there. The churchs approach to Holy Writ has been ignorant at best and disingenuous at worst. When interpreting the Bible, Christians have engaged in eisegesis rather than exegesis by injecting their preconceived notions into Scripture rather than extracting from the text what it clearly says.

Texts without context have become pretexts for proof texts! The grammar of the Scriptures (the Hebrew language of the first testament and the Hebrew thought underlying the Greek language of the second testament) has been largely minimized if not downright ignored. Likewise, the history and culture of the people through whom and to whom the sacred texts were committed have been virtually ignored. Entire theologies have been based upon a criterion of dissimilarity in which texts in the Apostolic Scriptures that have clear connections with the Hebrew Scriptures have been dismissed by some scholars as not being the authentic words of Jesus and the apostles but the work of subsequent redactors. It is as though Jesus had to have been born and lived in a vacuum and never influenced by his native language and culture. The very idea has given rise to a Christianity that has been wretched from its theological and historical moorings and set adrift in a maelstrom of nonbiblicalin far too many cases, anti-Biblicaltraditions, including postmodernism, consequentialism, secular humanism, and even demonic perversion.[iv]

If the cultural context within Scripture is so essential to the formation of the practics of our faith, is it not equally paramount in our understanding of Bible prophecy? Such casual dismissals caused prophecy teachers in the past century to declare anyone teaching that Israel would once again become a nation as a promoter of heresy. When Israel became a nation overnight in 1948, it shook the very foundations of many evangelical prophecy ministries worldwide. We need to learn from these mistakes and incorporate a Hebraic understanding into our hermeneutical process.

I said all of that to make a point: When Jesus spoke of the days of Noah, it served as a memory trigger to all of the hearers who could tap into over one thousand years of teaching regarding every aspect of the Noah narrative. In the times of Jesus, there were not chapters and verses to Scripture; these would not be added until the twelfth century by Stephen Langton with the introduction of the Latin Vulgate Bible. The sages of Israel would use a word or phrase to take the hearers to the portion of Scripture they were referring to. This is especially true with the Torah. Thus, as diligent students of Gods Word, we must labor to hear with Hebraic ears and dig deep into Noahs story to properly ascertain all that Jesus was referring to. Which was

1And it came to pass, when men began to multiply on the face of the earth, and daughters were born unto them,2That the sons of God saw the daughters of men that they were fair; and they took them wives of all which they chose. 3And the Lord said, My spirit shall not always strive with man, for that he also is flesh: yet his days shall be an hundred and twenty years. 4There were giants in the earth in those days; and also after that, when the sons of God came in unto the daughters of men, and they bare children to them, the same became mighty men which were of old, men of renown. 5And God saw that the wickedness of man was great in the earth, and that every imagination of the thoughts of his heart was only evil continually. 6And it repented the Lord that he had made man on the earth, and it grieved him at his heart. 7And the Lord said, I will destroy man whom I have created from the face of the earth; both man, and beast, and the creeping thing, and the fowls of the air; for it repenteth me that I have made them. 8But Noah found grace in the eyes of the Lord. (Genesis 6:18)

So many things seem to jump off the page as I approach these verses. Before I fully dive into the story of Noah, I want to touch on a biblical conundrum for the Transhumanist Movement contained within these passages of Holy Writ. In verse 3, God declares that He is going to limit the lifespan of man to 120 years. As we examine the text, we find as a mission of grace to mankind, Noah spent 120 years preaching repentance and building the ark. It was only after the canopy over the earth was broken up by God that the Flood came, and with it the dynamic changing of earths environment, which reduced mans lifespan. Prior to the Flood, according to biblical record, men would not even begin to have children until they approached their eighties or older! Now God sets the time limit to a mans life based on the number of years that Noah preached of the coming destruction and the need for repentance. (This also serves as a prophetic warning that there is a limit to how long God will extend His grace toward men.) The more time sinful man had to live and learn, the deeper he would become entrenched with the knowledge of the Tree of Good and Evil. If given enough time, mans insatiable appetite for dark knowledge would transform earth into a literal hell that God could not tolerate. Today, transhumanists[v] are endeavoring to circumvent Gods restraints on our lifespan. From what I have read in their literature, this is one of their primary goals. Seventy, eighty, or even one hundred and twenty years are not enough for them. While they lament over global warming and the perils of overpopulation, they seek to provide only a chosen few the opportunity to live hundreds of years, if not obtain near immortality. With the exponential acceleration of knowledge in the last days and the possibility of extending the life span of the Luciferian Elite, they may well have the time needed to thwart Gods intervention in Genesis 6! You see, God shortening mans lifespan to 120 years (and then later to seventy to eighty) was not a judgment against humanity; it was an expression of His grace toward all mankind.

And God saw that the wickedness of man was great in the earth, and that every imagination of the thoughts of his heart was only evil continually. (Genesis 6:5)

I want to examine verses 4 and 5 in a manner that is similar to a physicians diagnostic procedure: He would examine the presenting symptoms. Symptomology can be used in medicine and nutrition, and even in examining the health of a civilization. If certain symptoms are present in a patient, it will point toward the underlying disease that caused it. There is an intertwining aspect within the text of the corrupt Sons of God (Bene Elohim), the development of hybrid offspring, and the explosive evil within mens hearts. This wickedness that manifested within mankind was declared as great by God. In Hebrew, the word for great is rab (rab). This word means abounding, strong, exceedingly, and more numerous than.[vi] When evil has become so strong that it abounds throughout humanity and its perpetrators are more numerous than the righteous, it is a presenting sociological symptom of interference by the fallen Bene Elohim. (More on this later in both the new book The Shinar Directive as well as an upcoming online entry dedicated to the Communion with Darkness.)

That the sons of God saw the daughters of men that they were fair; and they took them wives of all which they chose. (Genesis 6:2)

There is great speculation regarding the identity of the Sons of God in Genesis 6:2. I prefer the traditional Hebraic view that these were angels and not men. Some would argue today that the sons of God represented the descendants of Seth. Dr. Chuck Missler explains the origin of the Sethite theory:

The strange events recorded in Genesis 6 were understood by the ancient rabbinical sources, as well as the Septuagint translators, as referring to fallen angels procreating weird hybrid offspring with human women-known as the Nephilim. So it was also understood by the early church fathers. These bizarre events are also echoed in the legends and myths of every ancient culture upon the earth: the ancient Greeks, the Egyptians, the Hindus, the South Sea Islanders, the American Indians, and virtually all the others.

However, many students of the Bible have been taught that this passage in Genesis 6 actually refers to a failure to keep the faithful lines of Seth separate from the worldly line of Cain. The idea has been advanced that after Cain killed Abel, the line of Seth remained separate and faithful, but the line of Cain turned ungodly and rebellious. The Sons of God are deemed to refer to leadership in the line of Seth; the daughters of men is deemed restricted to the line of Cain. The resulting marriages ostensibly blurred an inferred separation between them. (Why the resulting offspring are called the Nephilim remains without any clear explanation.)

Since Jesus prophesied, As the days of Noah were, so shall the coming of the Son of Man be, it becomes essential to understand what these days included.

Origin of the Sethite View

It was in the 5th Century A.D. that the angel interpretation of Genesis 6 was increasingly viewed as an embarrassment when attacked by critics. (Furthermore, the worship of angels had begun within the church. Also, celibacy had also become an institution of the church. The angel view of Genesis 6 was feared as impacting these views.)

Celsus and Julian the Apostate used the traditional angel belief to attack Christianity. Julius Africanus resorted to the Sethite interpretation as a more comfortable ground. Cyril of Alexandria also repudiated the orthodox angel position with the line of Seth interpretation. Augustine also embraced the Sethite theory and thus it prevailed into the Middle Ages. It is still widely taught today among many churches who find the literal angel view a bit disturbing. There are many outstanding Bible teachers who still defend this view.[vii]

In my own personal research, I have concluded that Dr. Missler is correct. All of the sages of Israel and the early Church fathers concluded that the sons of God referred to some category of angel and not righteous men. It should also be noted that, in the rabbinical literature of today, these sons of God are still interpreted as fallen angels as well. The only deviation from this interpretation is within Catholic theology and the Protestant theology that was influenced by Rome.

George H. Pember, in his classic work written in late 1800s, Earths Earliest Ages, came to the same conclusion:

These words are often explained to signify nothing more than the intermarriage of the descendants of Cain and Seth: but a careful examination of the passage will elicit a far deeper meaning.

When men, we are told, began to multiply on the face of the earth, and daughters were born unto them, the sons of God saw the daughters of men. Now by men in each case the whole human race is evidently signified, the descendants of Cain and Seth alike. Hence the sons of God are plainly distinguished from the generation of Adam.

Again; the expression sons of God (Elohim) occurs four times in other parts of the Old Testament, and is in each of these cases indisputably used of angelic beings.[viii]

To me, the concept of producing giants by the marriage of godly men with corrupt women is far-fetched. If that were the case, we would have giants living among us today. It is obvious that something more was going onsomething supernatural.

What this has to do with The Shinar Directive is centrally important, and not just for ancient days but the near future as well, regardless how incredible that may seem.

CONTINUED IN NEXT ENTRY

[i] Hermeneutical or hermeneutics: the study of the methodological principles of interpretation (as of the Bible).

[ii] Idiom: a form of a language that is spoken in a particular area and that uses some of its own words, grammar, and pronunciations.

[iii] Exegetical or exegesis: an explanation or critical interpretation of a text.

[iv] John D. Garr, Family Worship: Making Your Home a House of God (Atlanta: Golden Key Press, 2013) 1213.

[v] Transhumanist (abbreviated as H+ or h+): an international cultural and intellectual movement with an eventual goal of fundamentally transforming the human condition by developing and making widely available technologies to greatly enhance human intellectual, physical, and psychological capacities.

[vi] Strongs, # H07227.

[vii] Chuck Missler, Mischievous Angels or Sethites? http://www.khouse.org/articles/1997/110/.

[viii] George H. Pember, Earths Earliest Ages (Crane, MO: Defender, 2012)175176.

Original post:
transhumanism Biblical Life Assembly

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

ED Clinic Nashville TN, Erectile Dysfunction Treatment, Low T

We have your solution! Its well known in the medical community that mass-market drugs like dont work for as many as 50% of men. Thats not surprising to anyone in medicine with experience treating sexual health: a mans sexual function is complex and engages many systemsincluding the brain, heart, hormones, and vascular and nervous systems. But unfortunately for most men, the standard erectile dysfunction treatment is a little blue pill that gets results as infrequently as half of the time in some cases. That means disappointment for everyone involved.

Mens sexual issues can be symptoms of other, more serious conditions. Diabetes, strokes, heart attacks, high blood pressure, prostate issues, stress, obesity, and a variety of other issues can lead to problems in bed. So-called herbal or home-grown solutions and ED treatments not only under-deliver when its time to perform; they can also lead to complications when other conditions are involved.

Our staff of esteemed, experienced Nashville ED doctors approach your sexual health from a total mens health perspective. From Low Testosterone (Low T) treatments to safe, customized medications that wont counteract other medications or treatments, we have the experience and professional knowledge to improve your life, today!

Continued here:
ED Clinic Nashville TN, Erectile Dysfunction Treatment, Low T

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

‘Altered Carbon’ and TV’s New Wave of Transhumanism

The future belongs to those who can afford it. This may be virtually true in todays world, where surviving retirement can feel impossible, but its also the literal premise of Altered Carbon, Netflixs new prestige sci-fi series. Based on Richard K. Morgans novel of same name, the neo-noir is set several hundred years in the future, when human consciousness has been digitized into microchip-like stacks constantly being swapped into and out of various bodies, or sleeves.

This technology, along with innovations like human cloning and artificial intelligence, has given society a quantum leap, but its also sent socioeconomic stratification into overdrive, creating dire new realities for the poor and incarcerated while simultaneously producing an elite upper-class. Called Metsshort for Methuselahsthe members of Altered Carbons 0.001 percent have achieved virtual immortality thanks to vaults of their own cloned sleeves and cloud backups full of their stacks. Its either dystopia or utopia, depending on ones bank account.

Whatever your views on the shows plot, in which a former rebel supersoldier named Takeshi Kovacs (Joel Kinnaman), on ice in a stack prison, is revived and hired by a Met to solve the murder of his last sleeve, Altered Carbons best quality is its worldbuilding. In the 25th century, transhumanismthe belief that human beings are destined to transcend their mortal flesh through technologyhas reached its full potential, and some of its end results are not pretty, at all.

But Altered Carbon is only the latest bit of transhumanism to hit TV recently. From Black Mirrors cookies and Philip K. Dicks Electric Dreams mind-invading telepaths and alien bodysnatchers to Star Trek: Discoverys surgical espionage and Travelers time-jumping consciousness, the classic tropes of body-hopping, body-swapping, and otherwise commandeering has exploded in an era on the brink, one in which longevity technology is accelerating more rapidly than ever, all while most people still trying to survive regular threats to basic corporeal health and safety.

These tropes have enjoyed a healthy existence in sci-fi and horror for decades, but now more than ever transhumanism is ubiquitous in pop culture, asking us to consider the ethical, personal, political, and economic implications of an ideology with a goalimplementing technology in the human body to prolong and improve lifethat is already beginning to take shape.

A crucial fact to remember about transhumanism and the philosophies it inspired, including the ones modeled by Altered Carbons Mets, is that its conception was heavily rooted in eugenics. Though earlier thinkers had already produced work one could call transhumanist today, the term wasnt coined until 1951, by Julian Huxley, a noted evolutionary biologist (and brother to Brave New World author Aldous Huxley). Julian Huxley believed strongly in the fundamentally exclusionary theory that society would improve immensely if only its best members were allowed to procreate. In the speech in which he first used the word transhumanism, he claimed that in order for humans to transcend the tentative fumblings of our ancestors, society ought to enact a concerted policy to prevent the present flood of population-increase from wrecking all our hopes for a better world.

While he didnt necessarily believe the criteria for what constituted best should be drawn along racial or economic lines, the ideology Huxley promoted was inherently elitist. It also allowed for virtually as many interpretations as there are people, and plenty of those people, particularly those in powerespecially in Huxleys time, but also in the fictional future of Altered Carbondid and do believe best means white, straight, financially successful, and at least nominally Christian. As a result, the concept he named ended up being primarily conceptualized in its infancy by white men of privilege.

This, of course, didnt remain the main interpretation of transhumanism for long. In the years following Huxleys coinage, humans made profound leaps in technological innovation, first in computers and then in AI, which allowed more people to envision the possibilities of one day being able to transcend their organic limitations. The basic concept was easily repurposed by those whose oppression has always been tied to physical violencenotably people of color, LGBTQ people, and women.

By the early 1980s, scholars like Natasha Vita-More and Donna Haraway had revamped the concept with manifestos that argued transhumanism ought to be about diversity and multiplicity, about breaking down constructs like gender, race, and ability in favor of a more fluid, chimeric alternative in which each person can be many seemingly contradictory things at onceincluding human and machine. (As WIREDs Julie Muncy explains in her review of the first season, Altered Carbon touches upon but never really takes a stance on this dimension of a post-corporeal world.)

As Silicon Valley boomed, so did transhumanism. Millionaire investors have poured endless cash into anti-aging research, machine intelligence companies, and virtual reality; meanwhile, the possibility of extended or superhuman life has veered even further into becoming the exclusive purview of the extremely rich (and, more often than not, extremely white and extremely male). In 1993, mathematician and science-fiction writer Vernor Vinge pegged the arrival of the singularitythe moment at which technology, particularly AI, supersedes human intelligence and either eliminates humanity or fuses with it, allowing people to finally become post-humanat around 2030; by 2005 futurist Ray Kurzweil was agreeing with Vinge in his now-seminal book The Singularity is Near. (The Verge has a solid timeline of transhumanist thought here.)

Today, working organs are being 3D-printed. Nanites, while a few years off, are definitely on the horizon. And the technologies that fuel nightmare fodder like Black Mirror are becoming realities almost daily, which gives the overwhelming impression to laypeople that the Singularity, while perhaps still technically far off, is imminent.

Add privatized healthcare, police brutality, immigration, sexual assault, and plenty more extremely real threats to peoples physical bodiesnot to mention the exponential growth of the TV industry itselfand youve got the perfect cocktail for a flood of transhumanist sci-fi shows that give form to anxieties viewers have about both wanting to escape the physical confines of their blood-bag existences and being absolutely, justifiably terrified of what could go wrong when they actually do.

But however uncomfortable it may be, that dilemma is not accidental. It has become necessary to understanding and surviving our current techno-political moment. Whether enjoying the ecstasy of possibility in Altered Carbons disembodied immortality or writhing in the agony of imagining eternity as a digital copy of ones own consciousness, the roller coaster of emotions these shows elicit ought to be a major signal to audiences that now is the time to be thinking about the cost of pursuing technological immortality. If stacks and sleeves are indeed our inevitable future, the moral quandary wont lie in the body-swapping itselfitll be reckoning with who gets to do it and why.

View original post here:
‘Altered Carbon’ and TV’s New Wave of Transhumanism

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

HEALTHY LIFESTYLE I CAN’T CONTROL EVERYTHING IN MY LIFE …

Hi everyone!!I hope u guys are doing great. I thought to write a different blog post I feel to do so. A healthy lifestyle doesnt include only healthy eating also includes how healthy are your thoughts and how in peace youre with yourself. I left for 1-month social media I took a little break to []

My first blog for this year.Well, I want to wish everyoneHappy New Year and I hope this year will be good for all.To be honest, lately, Iveeaten a lot of food because of festive season so now I need to come back to my healthy lifestyleroutine.In this blog post, Ill like to talk about this []

Hi, everyone.I was not active lately I preferred to keep little distance from social media for 2 weeks.But this doesnt mean I left blogging Ill come stronger than before and with fresh blog posts.Well, just one day were away from 2018 I really hope this gonna be a fruitful year for each one of us. []

HELLOOOO finally Im back today well talk about Avocado, some might ask What Is Avocado? Avocado has a high fatty acid content but contains extremely low levels of cholesterol. Many people tend to stop eating avocado due to its high-calorie content, thinking that it may add to their weight. However, a number of calories are []

Hi everyone!Well, a lot of things are happening last days.One of them is trouble with my blog. But thanks, God I solved this. Yesterday I stayed 4 hours preparing my blog post. When I was editing & I thought to send to my friend and I copied. After that, blog post disappeared. To be honest []

HiI hope everyone is good.Well, lately I have some troubles with my blog thats why I couldnt post.I feel very bad about thisand I hope that very soon I can solve.Have a lovely weekend everyone.I hope that very soon everything will be OK and I can post here.

The word pumpkin comes from the Greek pepon for a large melon. The English named it pumpion or pompion, a term which dates back to 1547. Pumpkins are now grown all over the world with Antarctica being the sole exception. The term Cucurbitaceae may not sound immediately familiar, but the species within this plant family []

More:
HEALTHY LIFESTYLE I CAN’T CONTROL EVERYTHING IN MY LIFE …

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Myth about Testosterone Replacement and Prostate Cancer – page 2

The Memorial Sloan Kettering Experience

I was still giddy when I decided to look up the article detailing the experience of testosterone administration to men with metastatic disease from the Memorial Sloan Kettering Cancer Institute, published in 1981 by the urologic giant of his day, Willet Whitmore, and his colleague, Jackson Fowler. The short summary of the paper was quite damning. Over a course of eighteen years, fifty-two men with metastatic disease had undergone treatment with daily T injections, usually as a last-gasp treatment for their cancer. Of these fifty-two men, forty-five had experienced an unfavorable response, most within the first month of treatment.

This seemed pretty grim. Maybe Huggins had been right after all, despite basing his conclusions on a solitary patient. But then I discovered something equally shocking in the fine print of this article. Of the fifty-two men studied, all but four had already been treated with castration or estrogen treatment to lower testosterone. And of these four previously untreated men, one had an early, unspecified unfavorable response, while the remaining three men continued to receive daily T injections for 52, 55, and 310 days without apparent negative effects. In fact, one of these men was reported to have had a favorable response to T administration.

Drs. Fowler and Whitmore were impressed by the difference in outcomes for the untreated group of four men compared with the men who had already undergone hormonal treatment to lower testosterone. To explain the lack of negative effects on the untreated men, the authors postulated the following: Normal endogenous testosterone levels may be sufficient to cause near maximal stimulation of prostatic tumors. In other words, raising testosterone levels beyond the normal range did not seem to cause any increased cancer growth, even in men with metastatic disease!

This important concept was lost in the headline of the study, which clearly indicated that giving testosterone to men with prostate cancer was associated with rapid onset of negative consequences in most men. One had to read the article closely to learn that the headline applied only to men who had been previously castrated. Although this article has been cited for many years as evidence that T administration causes rapid and near-universal growth of prostate cancer (PCa), the authors in fact clearly made the point that the worrisome effects of T administration did not appear to occur in their small group of men without prior hormonal treatment.

It had been an amazing day in the library, which had long since turned to night. My head was spinning, but I wanted to tackle the last hurdle, the problem of testosterone flare. In the early 1980s, medications were developed to replace the need for surgical removal of the testicles for men with advanced prostate cancer. These medications are called LHRH agonists, and they continue to be used to this day. LHRH injections cause T concentrations to increase by 50 percent or more for seven to ten days, after which testosterone levels fall rapidly to castrate levels. This transient rise in testosterone is called testosterone flare.

Not long after LHRH agonists began to be used, there were reports of complications occurring after men began these treatments, and these complications were attributed to testosterone flare causing rapid growth of prostate cancer. These complications included the inability to urinate, worsening of bone pain, or, in the most tragic cases, paralysis due to collapse of a vertebra in which the cancer had eaten away the bone. As a result, for the last twenty years, it has been routine to add medications to block testosterone flare when starting a patient on treatment with LHRH agonists.

That night in the basement of Countway Library, I pulled all the original studies I could find of LHRH agonists, as well as reports of bad outcomes due to the flare. As I read, two things became apparent. First, many of the bad outcomes attributed to testosterone flare occurred a month or more after initiation of treatment. This meant that these complications occurred not when testosterone levels were high, but when testosterone levels had already dropped for some time to castrate levels.

Second, out of the substantial literature on LHRH agonists and prostate cancer, I could find only two articles that actually measured and reported PSA levels during the time of the testosterone flare. And here was the kicker: both articles showed absolutely no change in mean PSA values during the time of the testosterone flare! Curiously, neither article so much as mentioned this result.

PSA is an excellent indicator of prostate cancer growth. The fact that PSA did not rise in these men during the testosterone flare strongly suggested that the cancers did not grow during this time. Perhaps the complications attributed to testosterone flare were nothing more than the cancer progression that would have happened without any treatment at all.

It had been quite a day and night in the Countway Library. I left with my head spinning and a feeling that I had stumbled onto something very important. It was like the childrens story The Emperors New Clotheswe see what we want to see. And for two-thirds of a century, it had been assumed that raising testosterone increased prostate cancer growth. But maybe the emperor was naked.

Even in men with metastatic disease, there was no evidence I could find that raising testosterone made prostate cancer grow more than it would have anyway. Shockingly, the very publications cited so regularly to demonstrate a dangerous relationship between testosterone and prostate cancer contained evidence that this was not true.

Still, I was worried, because there was a bothersome unresolved paradox to explain. For decades, the storyline was that lowering testosterone levels caused prostate cancer to shrink away and raising testosterone levels caused it grow. The second part of this story was now seriously in doubt, yet the first part was obviously correct. In my own practice, I had seen the beneficial effects of lowering testosterone levels many times over in men with advanced prostate cancer. This part of Dr. Hugginss work was indisputable. But if lowering testosterone levels caused these cancers to shrink, how was it possible that raising testosterone levels did not cause the cancers to grow? This was a paradox that needed to be solved if physicians were to accept the possibility that testosterone therapy may not increase the risk of prostate cancer.

The answer turns out to be not all that complicated. All the reports of testosterone causing rapid growth of prostate cancer occurred in men who already had extremely low testosterone levels, due to castration or estrogen treatment. Once we get beyond the near-castrate range, it is hard to find any evidence that changes in T concentrations matter at all to prostate cancer. This is essentially what Drs. Fowler and Whitmore described in their 1981 article when they suggested that near maximal growth of prostate cancer is provided by naturally occurring T concentrations.

The experimental proof of this concept was provided by a landmark article published in 2006 using much more sophisticated means. In this study by Leonard Marks and colleagues, men with low testosterone received injections of testosterone or a placebo every two weeks for a total of six months. At the beginning and end of the study, measurements of testosterone and DHT (the more active form of testosterone within prostate tissue) were obtained from the blood and also from the prostate itself. The results showed that although blood concentrations of testosterone and DHT rose substantially in the T injection group, as expected, the concentration of testosterone and DHT within the prostate itself did not change at all and was similar to the group that received placebo injections. In addition, biochemical markers of prostate cell growth also did not change with T injections.

This study showed in elegant fashion that raising testosterone levels in the blood did not raise testosterone levels within the prostate. It is as if once the prostate has been exposed to enough testosterone, any additional testosterone is treated as excess and does not accumulate in the prostate. In technical terms, we say the prostate has been saturated with regard to testosterone. And it is this saturation that resolves the paradox of testosterone and prostate cancer.

Saturation explains the paradox in this way. At very low levels of T, near the castrate range, prostate growth is very sensitive to changes in T concentration. Thus, severely lowering testosterone will definitely cause prostate cancer to shrink; adding testosterone back will cause the cancer to regrow. However, once we get above the point where the prostate is saturated with testosterone, adding more testosterone will have little, if any, further impact on prostate cancer growth. Experimental studies suggest the concentration at which this saturation occurs is quite low.

In other words, the old analogy I learned in training was false. Testosterone is not like food for a hungry tumor. Instead, a much better analogy is, Testosterone is like water for a thirsty tumor. Once the thirst has been satisfied, prostate tumors have no use for additional testosterone. And the vast majority of men with low testosterone appear to have prostates that are not particularly thirsty.

I no longer fear that giving a man testosterone therapy will make a hidden prostate cancer grow or put him at increased risk of developing prostate cancer down the road. My real concern now is that men with low testosterone are at an increased risk of already having prostate cancer.

When my colleagues and I published our results in 1996 from prostate biopsies in men with low testosterone and PSA of 4.0 ng/mL or less, the 14 percent cancer rate was several times higher than any published series of men with normal PSA. In 2006, Dr. Rhoden and I published a larger study of prostate biopsies performed in 345 men. The cancer rate of 15 percent in this group was very similar to the first study. But whereas the cancer rate in 1996 was much higher than anything published to that date in men with PSA of 4.0 ng/mL or less, in 2006 the perspective had changed due to an important study called the Prostate Cancer Prevention Trial.

In that study, the cancer rate among men with a PSA of 4.0 ng/mL or less was also 15 percent. Because this value is identical to what we had found in our patients with low testosterone, it was suggested that the cancer rate in men with low testosterone is the same as the normal populationneither higher nor lower. However, the average age of men in our study was a decade younger than the men studied in the Prostate Cancer Prevention Trial (fifty-nine versus sixty-nine years). Almost half the men in the other study were seventy years or older, and age is the greatest risk factor we know for prostate cancer. The way I look at these numbers is that men with low testosterone have a cancer rate as high as men with normal T who are a decade older.

More importantly, in our study of 345 men, we found that the degree of testosterone deficiency correlated with the degree of cancer risk. Men whose testosterone levels were in the bottom third of the group were twice as likely to have cancer diagnosed on biopsy as men in the upper third. This finding adds to the concern that low testosterone is a risk factor for prostate cancer.

There is now additional data from around the world associating low testosterone and worrisome features of prostate cancer. For example, low testosterone is associated with more aggressive tumors. In addition, men with low testosterone appear to have a more advanced stage of disease at the time of surgical treatment.

Whereas I originally began to perform prostate biopsies in men with low testosterone because I was worried that treatment might cause a hidden cancer to grow, I now perform biopsies in these men because I am concerned they might have an increased risk of cancer. This risk is approximately one in seven for men with PSA values less than 4 ng/mL.

Because prostate cancer tends to be curable when caught early, I feel Ive done these men a service by finding their cancers before they have an abnormal PSA or DRE. With todays ability to monitor men with prostate cancer, not all of these men will necessarily require treatment. But the ones who have evidence of more aggressive tumors should definitely have an advantage by having their diagnosis made early.

For over sixty-five years, there has been a fear that testosterone therapy will cause new prostate cancers to arise or hidden ones to grow. Although no large-scale studies have yet been performed to provide a definitive verdict on the safety of testosterone therapy, it is quite remarkable to discover that the long-standing fear about testosterone and prostate cancer has little scientific support. The old concepts, taken as gospel, do not stand up to critical examination. I believe the best summary about the risk of prostate cancer from testosterone therapy, based on published evidence at the time this book is written, is as follows:

Low blood levels of testosterone do not protect against prostate cancer and, indeed, may increase the risk.

High blood levels of testosterone do not increase the risk of prostate cancer.

Treatment with testosterone does not increase the risk of prostate cancer, even among men who are already at high risk for it.

In men who do have metastatic prostate cancer and who have been given treatment that drops their blood levels of testosterone to near zero, starting treatment with testosterone (or stopping treatment that has lowered their testosterone to near zero) might increase the risk that residual cancer will again start to grow.

Prostate cancer with infiltration into bladder, lymph nodes, and urethra.

One of the most important and reassuring studies regarding testosterone and prostate cancer was an article published in the Journal of the National Cancer Institute in 2008, in which the authors of eighteen separate studies from around the world pooled their data regarding the likelihood of developing prostate cancer based on concentrations of various hormones, including testosterone. This enormous study included more than 3,000 men with prostate cancer and more than 6,000 men without prostate cancer, who served as controls in the study. No relationship was found between prostate cancer and any of the hormones studied, including total testosterone, free testosterone, or other minor androgens. In an accompanying editorial, Dr. Carpenter and colleagues from the University of North Carolina School of Public Health suggest scientists finally move beyond the long-believed but unsupported view that high testosterone is a risk for prostate cancer.

More and more physicians are coming around to recognize that testosterone therapy is not a true risk for prostate cancer, but it can take many years to alter established beliefs. Dont be surprised if your own doctor still raises this issue with you if you are considering testosterone therapy. If he objects to treating you for that reason, you should refer him to the article above, or one of the other review articles listed in the References at the back of this book. Even better, have him read this chapter!

Q. Im fifty-three years old and Ive been on testosterone therapy for two years, with good results. However, my father was diagnosed with prostate cancer at age seventy-five. Does this mean I need to stop testosterone?

A. There is a familial form of prostate cancer, but only in families in which prostate cancer occurs at age sixty-five or younger. Even in those families where a family member develops cancer at a young age, this does not necessarily mean that every other male in the family will develop cancer. Men with a family history of prostate cancer should be sure to have a yearly PSA and prostate exam. There is no need to discontinue testosterone treatment.

Q. My physician started me on testosterone, but I never had a prostate biopsy. I am sixty-four years old. Was this a mistake?

A. Because there is no evidence that testosterone treatment increases the risk of prostate cancer, it is fine to begin therapy as long as your PSA and DRE are normal. My own practice is to recommend prostate biopsy in men with low testosterone because our published data indicate there is an increased risk that cancer is already present in men with low testosterone, but this is by no means a standard recommendation yet among physicians.

Q. Why do you perform prostate biopsies on men with low testosterone if you dont feel that testosterone treatment will make a hidden cancer grow?

A. Because so many men with prostate cancer will not die from it, even without treatment, there is a fair amount of controversy over how aggressive to be in making the diagnosis. My perspective is that it is worth knowing the diagnosis, whether or not one chooses to be treated immediately. And because low testosterone seems to represent a small but definite increased risk, I feel that biopsy in men over fifty with low testosterone is worthwhile.

Q. A man in my bowling league was started on testosterone treatment and then developed prostate cancer one year later. Doesnt that show that testosterone is risky for prostate cancer?

A. If the wife of this man had switched to a new type of laundry detergent before the cancer was diagnosed, would we assume the cancer was caused by the detergent? Of course not. But we are predisposed to believe that testosterone therapy causes prostate cancer, so it is easy to hear a story like this and assume that testosterone therapy caused the cancer. Prostate cancer and testosterone therapy are both common in the United States, and both tend to occur in the same age range, so there will always be stories of men developing cancer some time after beginning testosterone therapy. If testosterone really made prostate cancers grow, then we should see high rates of cancer among men who start testosterone therapy. But we dont. Its false logic.

Q. Isnt it true that all men would eventually get prostate cancer if they lived long enough? If so, why does it even matter if testosterone were to increase the risk of something that is inevitable anyway?

A. Men do get prostate cancer at an increasingly high rate as they age. And it is true that most men diagnosed with prostate cancer would never have a moments trouble from it, even if it were left untreated, because most of these cancers grow so slowly that other medical conditions eventually become more troublesome. Yet for those with more aggressive forms of prostate cancer, the danger is very real. The challenge is to identify men at risk, because even high-grade prostate cancer is curable when caught early.

Q. It took more than thirty years for scientists to learn that hormones were dangerous for women and caused breast cancer. Isnt it possible well eventually find out the same is true for testosterone and prostate cancer?

Abraham Morgentaler, MD

A. The fear that hormone therapy is dangerous in women is currently being reevaluated, and it appears to not be as dangerous as was originally proclaimed. More to the point, it is critical to understand that men are not women and that testosterone is not estrogen. Anyone, particularly a scientist, must always allow for the possibility that new information will one day change current views. But after so much research over so many decades, there is little reason to believe that testosterone therapy poses a major risk for prostate cancer. As a medical student once said to me, If testosterone is really so dangerous for prostate cancer, why is it so hard to show it?

Abraham Morgentaler, MD, is an associate clinical professor of urology at Harvard Medical School, and is the founder of Mens Health Boston, a center focusing on sexual and reproductive health for men. He is the author of a number of popular books including The Male Body and The Viagra Myth.

Excerpted with permission from Testosterone for Life: Recharge Your Sex Drive, Muscle Mass, Energy and Overall Health by Abraham Morgentaler, MD, FACS. Published by McGraw-Hill.

If you have any questions on the scientific content of this article, please call a Life Extension Wellness Specialist at 1-800-226-2370.

Read more from the original source:
Myth about Testosterone Replacement and Prostate Cancer – page 2

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Top Nanomedicine Conferences|DrugDelivery meetings …

About Us

International Conference and Exhibition on Nanomedicine and Drug Delivery May 21-23, 2018 Tokyo, Japan

ConferenceSeries Ltdis a renowned organization that organizes highly notablePharmaceutical Conferencesthroughout the globe. Currently we are bringing forth2ndInternational Conference on Nanomedicine and Drug Delivery(NanoDelivery 2018) scheduled to be held duringMay 21-23, 2018 at Tokyo, Japan. The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

2018 Highlights:

Nanomedicine and drugdelivery will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nano medicine and drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as Japan, China, India and other economies in the region. Japan is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery.

For More PS:https://nanomedicine.pharmaceuticalconferences.com/

(Click here for any queries)

Nanomedicine and drugdelivery can address one of the greatest challenges in the post-genomic era of the 21st century making the essential connections between Academics and industry professionals.

To meet these challenges, the field of Nanomedicine and drugdelivery has undergone exponential growth during the last 5 years. Technologies such as Personalized Nanomedicine, Design of Nanodrugs, Synthesis of Nanoparticles for Drug Delivery, Regenerative Medicine and Tissue Engineering, Nanomedicines and Biomedical applications, Nanomaterials for drug delivery, Regulatory Aspects Towards Approval of Nanomedicine, NanoPharmaceutical, Industry and Market processing and drug delivery promise to transform the world of Advanced nanomedicines and drug delivery much in the same way that integrated and transformed the world of pharmaceutical sciences.

Nanodelivery 2018 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in nanomedicine and drug delivery, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Nanomedicine and drugdelivery International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Nanodelivery 2018 conference and Exhibition. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will see at the Nanodelivery Exhibition, you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from todays industry leaders.

The Nanodelivery 2018 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Who’s Coming to Nanodelivery 2018?

The field ofNano Deliverynow has pivotal roles in electronics, biology and medicine. Its application can be appraised, as it involves the materials to be designed at atomic and molecular level. Due to the advantage of their size, nanospheres have been shown to be robustdrug delivery systemsand may be useful for encapsulating drugs and enabling more precise targeting with a controlled release. In this review specifically, we highlight the recent advances of this technology for medicine and drug delivery systems. Nanomaterialsrange from 10200 nm up to a few micrometres in size, and include nano- and microparticles, nanotubes and quantum dots.

Nanotechnological devices are made from metals, polymers, lipids and organic substances as well as from macromolecules such as dendrimers, antibodies, micelles, liposomes and nanofibers. Nanomedicine makes use of these nanostructures for diagnostic or therapeutic applications in all fields of medicine, using them for drug delivery, biosensors, neuro-electronic interfaces, in vivo imaging, and cell-specific molecular interactions, where “cell repair machines” could revolutionize medicine and the medical field. Asdrug delivery systems,nanoparticlescan be designed to improve the pharmacological and therapeutic properties of drugs. The strength of nanoparticulate drug delivery systems is their ability to alter thepharmacokineticsand biodistribution of drugs.

ConferenceSeries Ltdorganizes aconference seriesof 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 morescientificsocietiesand publishes 700+Open access journalswhich contains over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1:Advanced Nanomedicine

Advanced Nanomedicineseeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, andNanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, sincenanomedicinesmust be biocompatible for clinical application.

Related Conferences:

26th International Conference on Advanced Nanotechnology October 04-05 2018 Moscow, Russia; 18th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care September 05-06, 2018 Auckland, Newzealand;International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine April 18-19, 2018 Las Vegas, Nevada, USA; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology, April 09-11, 2018 Amsterdam, Netherlands; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017

Track 2:Design of Nanodrugs

To reach target cell, designing of nanodrugs are major aspects, where researcher interested for developing novel Nanodrugs.

Aimed and specially designed session for researchers developing Nanodrugs for delivery ofamino acids,Nucleic acidsand proteins. The session Design of Nanodrugs includes: Novel Drugs to Nano Drugs, Nanodrugs for Cancer Therapy, Nanodrugs for Veterinary Therapeutics, Nanodrugs for Medical applications and Nanodrugs forHerbal medicinesand Cosmetics.

Related conferences:

14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine April 18-19, 2018 Las Vegas, Nevada, USA; 4th International Conference and Expo on Drug Discovery, Designing & Development September 06-07, 2018 London, UK; International Conference on Biomedicine & Pharmacotherapy August 06-07, 2018 Osaka, Japan; 16th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Track 3:Nanomedicine and Nanotechnology

Nanotechnology for canceris a field that incorporates the studies related to nanosized particles, their function and behavior with respect to different systems. The tremendous capabilities of nanoparticles have changed the perspective and scope ofnanotechnologytowards development into an adjuvant field for the remaining fields of life sciences. The role of nanotechnology in the field of pharmaceutics has tremendously changed the way of our understanding about drugs, nanodrugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug andadvances in nanotechnology.

Nanotechnologyis an important field of modern research dealing with design, synthesis, and manipulation of particle structures ranging from approximately 1-100 nm.

The session Design of Nanomedicine and Nanotechnology includes broad topics like: Carbon Nanotubes,Nanoparticles, Gold Nanoparticles, Silver Nanoparticles, Magnetic Nanoparticles, Nano Micro Particles, Nanocomposite Microspheres, Biosensors and Nanobioelectronics, Bio inspired materials and drug delivery and Nanobiomechanics and Nanomedicine.

Related conferences:

Nanomaterials Conference,March 30-31, 2017, Madrid, Spain;MedicalNanotechnologySummitMay 22-23, 2017, Osaka, International Conference onPharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2ndInternational Conference onNanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017, Prague, Czech Republic; EuropeanNanomedicineMeeting 2017, April 3-4, 2017, London, UK; 19thInternational Conference onNanotechnology and Nanomedicine, June 21 – 22, 2017, Vienna, Austria; 4thWorld Congress and Expo onNanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine,Royal Society-NanoTechnology and NanoScience.

Track 4:Synthesis of Nanoparticles for Drug Delivery

Nanoparticles(NPs) have wide range of applications in areas such as health care, cosmetics, food and feed, environmental health, mechanics, optics, biomedical sciences, chemical industries, electronics, space industries, drug-gene delivery, energy science, optoelectronics, catalysis, single electron transistors, light emitters, nonlinear optical devices, and photo-electrochemical applications.

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such asliposomesare used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle

Nanocarriers, Gold Nanoparticles, Silver Nanoparticles, Liposomes, ligands,Nanoemulsions, Solid Lipid Nanoparticles, Polymeric Nanoparticles, Dendrimer Nanocarriers, Silica materials and Carbon Nanocarriers,nanotechnology and medicine.

Related conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 5:Regenerative Medicine and Tissue Engineering

The promise of regenerative medicine is truly remarkable.Regenerative medicineis a new branch of medicine that attempts to change the course of chronic disease, in many instances regenerating failing organ systems lost due to age, disease, damage, or congenital defects. The area is rapidly becoming one of the most promising treatment options for patients suffering from tissue failure.

TissueEngineering and Regenerative Medicine is appealing to scientists, physicians, and lay people alike: to heal tissue or organ defects that the current medical practice deems difficult or impossible to cure.

It covers numerous topics, such as stem cells, cell culture, polymer synthesis, novelbiomaterials, drug delivery, therapeutics, and the creation of tissues and organs.

This session dedicated to helping provide research-based solutions to issues related to human diseases and include with sessions as: tissue engineering, Organ fabrication, Tissue printing, Biomaterials, Biologic scaffolds, Hydrogels, Cell seeded matrices, Bioreactor design, Mechanical conditioning of engineered tissues, Mechanical properties of engineered tissues, Physiological properties of engineered tissues, Clinical outcomes of engineered tissue implantation, Cell-based therapies.

Related conferences:

Tissue Engineering and Regenerative Medicine ConferenceAug 20-22, 2017 Baltimore, USA;Stem Cell And Regenerative Medicine MeetingsMarch 20-22, 2017 Berlin, Germany; 8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USA; 5th InternationalConference onCell and Gene TherapyMay 19-21, 2016 San Antonio, USA; InternationalConference on Restorative MedicineOctober 24-26, 2016 Chicago, USA; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd InternationalConference on Tissue preservation and Biobanking September12-13, 2016 Philadelphia USA;Conference on Cardiac Development, Regeneration and RepairApril 3 7, 2016 Snowbird, Utah, USA; TheConference onStem Cell Development,May 22-26, 2016 Hillerd, Denmark;Conference onHematopoietic Stem Cells: June 3-5, 2016 Heidelberg, Germany;ISSCR Pluripotency ConferenceMarch 22-24, 2016 Kyoto, Japan ,Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT),American Association for the Advancement of Science , Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 6:Nanomedicine in Theranostics

Theranosticnanomedicineis emerging as a promising therapeutic paradigm. It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them bothimagingand therapeutic functions. The resulting nanosystems, capable of diagnosis,drug deliveryand monitoring oftherapeuticresponse, are expected to play a significant role in the dawning era ofpersonalized medicine, and much research effort has been devoted toward that goal.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 7:Nanomedicines and Biomedical Applications

Nanomedicineseeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, andNanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, sincenanomedicinesmust be biocompatible for clinical application.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 8:Drug Delivery Research

Drug Delivery Conferences attains greater global significance asDrug Deliveryplays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics likelipid Polymersto enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs.In vitro & in vivodissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latestTargeted drug deliveryis a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.Pharmacokineticbehavior indrug designanddrug developmentfor safety issues arising either as a result of animal toxicity testing or in the clinical program itself

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3ndInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3ndInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 9:Novel Drug Delivery Systems

To maximize knowledge of the current researcher on developingdrug delivery systemsvia Novel techniques forPharmaceutical formulationdevelopment, Drug Delivery conference themed quality topics onLiposomes, Dendrimer,Targeted Drug Deliverydesign, versatile polymer in Drug Delivery andControlled Drug Delivery, Trans mucosal Drug Delivery, Blood Brain Barrier, Optimization of pharmaceutical products, SustainedDrug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development andPharmacology.

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3ndInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3ndInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 10:Smart Drug Delivery Technology

To maximize knowledge of the current researcher on developingdrug deliveryviaPharmaceutical formulation, Smart Drug Delivery conference themed quality topics onDrug Targeting,Drug Designing,Drug evaluation,Drug Delivery and Therapeutics, Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3rdInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3rdInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 11:Nano Pharmaceuticals

Pharmaceutical NanotechnologyforDrug Delivery using Nanotechnologysession plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology,anticancer drug development,pharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestinglypharmaceutical sciencesare usingnanoparticlesto reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient.

Nano technology session includesdrug delivery using nanotechnology,Pharmaceutical technology, Nanoparticles permeability to BBB,Cancer drug targets, Nanoparticles application,Pancreatic Cancer, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarrier, Carriers for nanotechnology, various nanostructures, magnetic nanoparticles. In this reviewPolymer Nanotechnologyfor Drug Delivery,Nano compositematerials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.

Related Conferences:

20thInternationalConference on Nanoscience, Dec 19-20, 2017 Osaka, Japan 11thInternationalConference on Molecular Nanotechnology, October 20-22, 2016 Rome, Italy, UK; InternationalConference on Nano medicine, July 24-25, 2017 Melbourne, Australia;Conference on Nanotechnologyin Health Care , July 24-25, 2017 Melbourne, Australia; 3rdInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3rdInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 12:Biopharmaceutics and Biologic Drugs

Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products. The process of movement of drug from its site of administration to the systemic circulation is called as absorption. The concentration of drug in plasma and hence the onset of action, and the intensity and duration of response depend upon the bioavailability of drug from its dosage form. Bioavailability is defined as the rate and extent (amount) of drug absorption.Biologic Drugs, or biologic response modifiers, are medications genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease. Biologics target proteins, cells and pathways responsible for the symptoms and damage of rheumatoid arthritis and other types of inflammatory arthritis. Biologic response modifiers (biologics for short) are drugs that are genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease.

Related conference:

13th International Conference on Biopharma and BiotherapeuticsOctober 24-25, 2018 Boston, Massachusetts, USA ,Global Summit on Biopharma and BiotherapeuticsMontreal, Canada May 14-15, 2018,International Conference on Nano Medicine and NanoparticlesApril 18-19, 2018 Las Vegas, USA11th European Biosimilars CongressApril 26-27, 2018 Rome, Italy

Track 13:Nano Biotechnology

Nanobiotechnologyis the intersection of nanotechnology and biology.Nanobiotechnologyhas multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases bygene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 14:Nano Pharmaceutical Industry and Market

Nano Pharmaceutical IndustryCompanies and Market session is beginning to change for small, medium, and large scale pharmaceutical Co,biopharmaceutical Manufacturing and Industries, generic drugscompanies,contract drug delivery companieswhich can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of theClinical bio therapeuticsthemselves. This session includes Rheological behavior,Pharmaceutical Guidelines,Pharmaceutical companies and regulatory guidelinesperspectives, Advances in computational modeling forbioavailability,drug Stabilityof Pharmaceutical products which are driving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases.

Related Conferences:

International Conference onPharma Marketing Conference, November 17-19, 2016 Alicante, Spain; 4th Annual conferences onEuropean Pharma Congress, June 13-15, 2016 Berlin, Germany; 2ndInternationalConference on Biologic Drugs, September 15-17, 2016 San Antonio, USA; 3rdWorldCongress on PharmacologyAugust 08-10, 2016 Birmingham, UK; 2ndInternationalConference on Parenterals, December 05-07, 2016 Dallas, Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016 Dallas, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 15:Regulatory Aspects Towards Approval of Nanomedicine

Nanoethicsis the study ethical and social implications of nanotechnologys. It is an emerging but controversial field.Nanoethics is a debatable field.As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas likeresearch ethics, environment,global equity, economics, politics, national security, education, life extension and space exploration.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Summary of Nanodelivery 2018 Conference:

Nano Delivery 2018is an emerging field of engineering andlife sciencesthat promises to revolutionizemedicineand medical technology. There are numerous applications ofnanomedicineandDrug Delivery using Nanotechnologyin medicinal diagnostics. These include improvedimaginingof the human (or any) body and detectingtumorsthat are only a few cells in size.

The idea thatpharmaceutical agentsshould be delivered specifically to diseased cells holds the promise of a variety of benefits. The promise of individualized medicine is that it is efficient.Targeted drug-deliveryallows doctors and patients to benefit from small dosages at just the right place and thus from fewer side effects.

Nanomedicine hastherapeuticuses as well. Nanotechnology is capable of delivering medication to the exact location where they are needed, hence lesser side effects. It can also be used to destroy harmful organisms orcancer cellsby interrupting their division process. Nanoprobes can be made to generate radiation that could kill bacteria, viruses and cancer cells. Nanotechnology also theoretically allows the mimicking of natural biological processes, e.g. repair of damaged tissues or acting as artificial red blood cells to transport oxygen.

The global market forhealthcare nanotechnologyis expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.

Importance & Scope of Nano Delivery:

Read the original post:
Top Nanomedicine Conferences|DrugDelivery meetings …

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Journal of Nanomedicine & Nanotechnology – Open Access Journals

NLM ID : 101562615SJR H Index:13, Google Scholar h5-index: 13ICDS = 3.8ICV Value: 101.22

Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.

Journal of Nanomedicine & Nanotechnology covers wide varieties of topics such as molecular nanotechnology, nanosensors, nanoparticles, nanodrugs, Nanomaterials, nanobiotechnology, nanobiopharmaceutics, nanoelectronics, nanorobotics, etc.. The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.

The journal is using Editorial Manager System for quality peer review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Nanomedicine & Nanotechnology or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

The Journal of Nanomedicine & Nanotechnology is a scientific journal which provides an opportunity to share the information among the medical scientists and researchers. The main function of open access publishing platforms is to present the content online, making it available to all, and link this information with useful scientific data.The Journal of Nanomedicine & Nanotechnology aims to publish articles bimonthly and is one of the best open access journals of scholarly publishing.

Journal of Nanomedicine & Nanotechnology is anacademic journal which aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of Research articles, Review articles, Case reports, Short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

You can find a clear view of peer review process by clicking here.

Material Science Research: Material Science and NanotechnoMaterials are crucial to the performance and reliability of virtually every technology and the vitality and health of any living organism. The central theme of materials science and engineering is that the process by which a material comes into being determines its structure, which in turn controls its properties and ultimately its functional performance.

Nanotechnology is the engineering of functional systems at the molecular scale. It is the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.

Related Journals of NanotechnologyNanoscience and Nanotechnology, Nanoscience and Nanotechnology Letters, Journal of Nanomedicine & Biotherapeutic Discovery, IEEE Transactions on Nanobioscience, Journal of Biomedical Nanotechnology, Photonics and Nanostructures – Fundamentals and Applications

Nanobiotechnology is the application of nanotechnology to the life sciences: The technology encompasses precision engineering as well as electronics, and electromechanical systems as well as mainstream biomedical applications in areas as diverse as gene therapy, drug delivery and novel drug discovery techniques.

Related Journals of NanobiotechnologyJournal of Biomedical Nanotechnology, Research Journal of Nanoscience and nanotechnology, Nature Nanotechnology Journal, Nanomaterials & Molecular Nanotechnology, Nature Nanotechnology, Nano Letters, Advanced Materials, Nano Today

A Nanocomposite is a multiphase solid material where one of the phases has one, two or three dimensions of less than 100nm, or structure having nano-scale repeat distance between the different phases that make up the material.

Related Journals of Nanocomposites

Journal of Nanomaterial and Nanotechnology, International Journal of Nanotechnology Impact Factor, Journal of Nanomedicine & Biotherapeutic Discovery, Scripta Materialia, Nanoscale, Lab on a Chip – Miniaturisation for Chemistry and Biology, Materials Science & Engineering A: Structural Materials: Properties, Microstructure and Processing

The Integrated Project Nanobiopharmaceutics aims at the development of innovative multidisciplinary approaches for the design, synthesis and evaluation of functionalised nano-carriers and nano-particle-based micro-carriers for the treatment of various diseases based on targeted, controlled delivery of therapeutic peptides and proteins (biopharmaceutics).

Related Journals of NanobiopharmaceuticsJournal of Nanomedicine & Biotherapeutic Discovery, Journal of Nanobiomedical Impact Factor, Journal of Obsessive-Compulsive and Related Disorders, Journal of Homotopy and Related Structures, Journal of Venomous Animals and Toxins including Tropical Diseases

Nanoelectronics is one of the major technologies of Nanotechnology. It plays vital role in the field of engineering and electronics.

Related Journals of Nanoelectronics Journal of Nanotechnology and Electrophysics, Nano Research & Applications, ACS Applied Materials and Interfaces, International Journal of Nanotechnology Applications, Biosensors and Bioelectronics, Journal of Physical Chemistry C, Nanomedicine: Nanotechnology, Biology, and Medicine

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology.

Related Journals of Nanomedicine Nanomaterials & Molecular Nanotechnology, Pharmaceutical Nanotechnology, Journal of Biomedical Nanotechnology, International Journal of Nanomedicine, Nanomedicine: Nanotechnology, Biology and Medicine, Journal of Nanomedicine Research, European Journal of Nanomedicine

Nanotoxicology is a branch of toxicology concerned with the study of the toxicity of nanomaterials, which can be divided into those derived from combustion processes (like diesel soot), manufacturing processes (such as spray drying or grinding) and naturally occurring processes (such as volcanic eruptions or atmospheric reactions).

Related Journals of NanotoxicologyNanomedicine & Nanotechnology, Nanotechnology Journal Lists, Nano Journal Impact Factor, Microscale Thermophysical Engineering, Microelectronic Engineering, Nano Biomedicine and Engineering, Nano-Micro Letters

Nanoengineering is the practice of engineering on the nanoscale. It derives its name from the nanometre, a unit of measurement equalling one billionth of a meter. Nanoengineering is largely a synonym for nanotechnology, but emphasizes the engineering rather than the pure science aspects of the field.

Related Journals of NanoengineeringJournal of Nanoresearch, Review in Nanoscience and Nanotechnology, Nature Nanotechnology Journal, Research & Reviews: Journal of Pharmaceutics and Nanotechnology, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Nanotoxicology, Precision Engineering, Nanomedicine, Nanotechnology

The spontaneous association of molecules under equilibrium conditions into stable, structurally well-defined aggregates.

Related Journals of NanofabricationsJournal of Nanotechnology Impact Factor, Nanotechnology Journal Lists, Journal of Nano, Nanomaterials & Molecular Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine, Beilstein Journal of Nanotechnology

Nanofluidics is often defined as the study and application of fluid flow in and around nanosized objects.

Related Journals of Nanofluidics Research Journal of Nanoscience and Nanotechnology, Nano Journal Impact Factor, Journal of Nanotechnology and Electrophysics, Journal of Bionanoscience, Nanotechnology, Science and Applications, Journal of Nanobiotechnology, Plasmonics, Biomedical Microdevices

Nanohedron aims to exhibit scientific images, with a focus on images depicting nanoscale objects. The work ranges from electron microscopy images of nanoscale materials to graphical renderings of molecules. Scientific images lying outside the realm of nanoscience such as algorithmic art or confocal microscopy images of cells will also be considered.

Related Journals of Nanohedron Biomicrofluidics, Nanotechnology Journal Lists, Nano Journal Impact Factor, IEEE Transactions on Nanotechnology, Microfluidics and Nanofluidics, Journal of Micromechanics and Microengineering

Nano Cars Into the robotics is new technology which is useful for designing robots. Difference in exisiting robotics and nano cars is this system works as nervous system where as in existing system stepper motors are used.

Related Journals of Nanocars Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Review in Nanoscience and Nanotechnology,Nanomedicine & Biotherapeutic Discovery, ACS Nano, Advanced Functional Materials, Journal of Physical Chemistry Letters, Biomaterials, Small, Nano Research

Nanothermite, as the name suggests, is thermite in which the particles are so small that they are measured in nanometers is an ultra-fine-grained (UFG) variant of thermite that can be formulated to be explosive by adding gas-releasing substances.

Related Journals of NanothermiteNanoscale Research Letters, Journal of Nanobiomedical Impact Factor, International Journal of Nanoscience, Microelectronics and Reliability, Journal of Nanoparticle Research, AIP Advances

A sequence of nanoscale C60 atoms arranged in a long thin cylindrical structure. Nanotubes are extremely strong mechanically and very pure conductors of electric current. Applications of the nanotube in nanotechnology include resistors, capacitors, inductors, diodes and transistors.

Related Journals of NanotubesNanotechnology journals, Nature Nanotechnology Journal, Nano Journal Impact Factor, ACM Journal on Emerging Technologies in Computing Systems, Science of Advanced Materials, Journal of Nanophotonics

Having an organization more complex than that of a molecule.

Realated Journals of Supramolecule Plasmonics, Journal of Biomedical Nanotechnology, International Journal of Nanoscience, Journal of Nanobiomedical Impact Factor, Biomedical Microdevices, Biomicrofluidics, IEEE Transactions on Nanotechnology

Nanoionics is the study and application of phenomena, properties, effects and mechanisms of processes connected with fast ion transport (FIT) in all-solid-state nanoscale systems.

Related Journals of Nanoionics Journal of Nanoresearch, Journal of Nanoscience and Nanotechnology, Journal of Biomedical Nanotechnology, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine

Nanolithography is the branch of nanotechnology concerned with the study and application of fabricating nanometer-scale structures, meaning patterns with at least one lateral dimension between 1 and 100 nm.

Related Journals of NanolithographyInternational Journal of Nanotechnology, Journal of Nanotechnology Impact Factor, Nanoscience and Nanotechnology Letters, Nano Research, Scripta Materialia, Nanoscale, Lab on a Chip – Miniaturisation for Chemistry and Biology

Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and properties. Particles are further classified according to diameter.

Related Journals of Nanoparticles Journal of Nanoscience and Nanotechnology, International Journal of Nanoscience, Journal of Nanomaterial and Nanotechnology, Journal of Nanoparticle Research, Journal of Nanoparticles, International Journal of Nanoparticles,

Exploitation of biomaterials, devices or methodologies on the nanoscale.

Related Journals of Bionanoscience Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Journal of Biomedical Nanotechnology, Recent Patents in Nanotechnology, Journal of Bionanoscience, BioNanoScience, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials

Read the original post:
Journal of Nanomedicine & Nanotechnology – Open Access Journals

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Sermorelin vs HCG for Weight Loss – Nu Image Medical

Last week we discussed the differences between HGH and HCG for weight loss, however we didn’t discuss Sermorelin vs HCG for weight loss and how this HGH stimulating peptide is different. Sermorelin is a HGH secretagogue, or a peptide that causes the body to naturally release its own HGH. This way, the HGH that is produced is natural and there are no concerns about the purity of the actual hormone since it is produced by the body. Sermorelin causes a gradual rise in HGH production after being injected for several weeks at a time. Sermorelin directly causes the body to create its own HGH, while the hormone HGH itself is often injected for the purpose of weight loss and anti-aging. Sermorelin and HGH have different effects on the body, and Sermorelin has become a popular anti-aging treatment that also has some weight loss gains. However, between Sermorelin and HCG, HCG is still the better hormone for weight loss for reasons explained below.

HCG is the most widely used and effective hormone for the specific purpose of weight loss. It is clinically proven to assist with weight loss on a very low calorie diet. Most people try Sermorelin therapy for the purpose of anti-aging, and it has a wide range of positive effects on the body. Weight loss is certainly possible with Sermorelin therapy but it is rarely the primary goal of the treatment. The usual primary goal of Sermorelin injections is to replace any reduced HGH levels that are the result of aging or other causes. Sermorelin can result in a moderate amount of weight loss but it often needs to be combined with exercise and a healthy diet, and it can be much more difficult to lose weight with Sermorelin alone compared to HGH.

Unlike the HCG diet, there is no specific Sermorelin diet that will optimize the weight loss potential of the treatment. Sermorelin results in weight loss when administered as a treatment over a long period of time. The weight loss that normally results is usually around 5 to 10 pounds after several months of treatment, usually four to six months. This assumes very little to no exercise. The HCG diet on the other hand is designed to help the body lose as much weight as possible by maximizing the effectiveness of the hormone. The diet avoids specific foods that can cause an interaction with the hormone, and it was developed through clinical research. There is no such protocol for Sermorelin outside of general guidelines for eating healthy and exercising on a regular basis.

As previously mentioned, weight loss is only a side benefit of Sermorelin therapy, and the amount of weight loss will vary dramatically from one person to another. In general, the weight loss that Sermorelin can offer is very limited. It is a good treatment for many people who are HGH deficient, and it is a good way to maintain a healthy weight when combined with a healthy diet and exercise. However, HCG is far better for the purpose of losing a large amount of weight in a short period of time. HCG can realistically cause up to 40 pounds of weight loss in just six weeks when combined with the very low calorie diet protocol. It has been proven time and time again to be one of the best weight loss treatments in the world, and for patients who intend to lose weight there is simply no other hormone or treatment that will work better in the vast majority of cases.

When combined with exercise, Sermorelin is great for maintaining a healthy weight. The loss of HGH that occurs with aging is correlated with an increase in body fat and a decrease in muscle mass. The loss of HGH also slows down the body’s fat metabolism, which is why it is easier to put on weight as we start to age and harder to lose it. Sermorelin helps with all of that and more. It helps restore a more youthful metabolism, so that the food you do eat isn’t converted into fat as easily. It also helps with improving muscle mass which in turn burns more calories when you are sedentary, and it helps burn abnormal fat that you already have. In general, it’s a great option for aging adults to help them maintain their weight.

Sermorelin is also proven to be effective at helping adults restore a more normal sleep cycle. An abnormal sleep cycle and insomnia are both associated with weight gain. People who stay up for longer periods of time are more likely to eat to stay alert or out of boredom, and many sleep disorders and problems are associated with weight gain. Sermorelin has been reported to help adults improve their sleep within just days of starting the treatment, and by getting higher quality sleep and more sleep, it can be easier to maintain a healthy weight. Most adults need a minimum of 7 hours of sleep per night to be adequately rested, and if you are an aging adult with weight to lose as well as sleep problems, you may definitely want to consider starting Sermorelin therapy.

You will only lose a very small amount of weight on Sermorelin therapyunless you exercise regularly. One of the main benefits of taking Sermorelin is the fact that you will recover more quickly from your workouts, and you will build more muscle than you would without the treatment. Just as a young person can exercise while maintaining a high energy level, Sermorelin can help improve your energy levels when you are working out and help your body get more out of your workouts. The result is that your body will respond better to physical activity. To really see significant weight loss results with the therapy you do have to exercise regularly. However, exercise is definitely not a requirement for the HCG diet and as a result it is often more convenient for patients, especially those with a lot of pounds to lose.

A main benefit of the HCG diet is that it never requires exercise for weight loss and it works fast. Anyone who wants to lose weight as quickly as possible should consider starting the HCG diet. Once the diet has been completed, if the patient has a HGH deficiency, it can easily be corrected with Sermorelin therapy and it should. Although HCG is better for weight loss than Sermorelin, Sermorelin is often necessary for many patients who have a small to significant HGH deficiency. It offers a great way for patients to maintain a youthful metabolism, lose a few pounds, put on more muscle and get more out of their workouts, but the HCG diet offers the fastest way to lose weight in the shortest period of time.

Continue reading here:
Sermorelin vs HCG for Weight Loss – Nu Image Medical

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Best HCG Drops Review: Top 3 Weight Loss Drops of 2017

Before trying on yourself, Let us first learn what HCG is?

Human chorionic gonadotropin (HCG) is a hormone which supports the normal development of an egg in a womens ovary. It stimulates the release of the egg during ovulation. In a womans body, it is produced during the early stages of pregnancy. The fundamental function of this hormone is to secure the embryo in the initial three months. HCG is additionally regularly utilized clinically, as infusions, to achieve ovulation in the female body.

A pleasing fact about HCG is, it burns the excess fat, which gets accumulated around arms, waist, and thighs. Now, a new weight loss diet has emerged in practice, and that is HCG Diet.

These drops are safe,effective, and helps burn excess fat and lose extra pounds.The method of weight loss adopted by using these drops is popularly known as HCG weight loss.

What is that which can help you in losing weight? If running on a treadmill or swimming can help you lose weight; your tendency to eat more due to burnt calories as a result of exercise adds back extra pounds.

So do remember, only an extremely low-calorie diet without workouts can help you lose weight. Thats where HCG drops come into action. They effectively help to live on a low-calorie diet.

Let us now look at scientifically, how HCG drops stimulates low-calorie diet.

These drops stimulate you to have an ultra-low calorie diet, which sets the metabolism process in a different way, with which you can easily lose at least a pound a day, with a perfect combination of an as low as a 1200,800,500 calorie diet and a few HCG diet drops.

This is because HCG diet helps you cut down on calories to the lowest extent. By this method for 8 weeks continuously, you ought to see a drastic change in the shape of your body.

The best part of this diet is, you get to lose weight without feeling hungry or weak.The HCG diet drops are safe to consume. It is also proven to be effective for people, where they have seen their thighs, waist, and shoulders coming back in shape.

You tried every weight loss method. You failed. And now, you have given up. However, dont miss out on one last opportunity andthat is HCG drops.

However, choosing the right HCG drops can become a major challenge for you. In current growing capitalist economies, consumers get to choose from a wide range of products.

If you are serious about choosing a method of weight loss, through which you can see a drastic change, then HCG diet drops are the only way. However, if you have to get it right, then choosing the best HCG drops is what it takes. This isnot an easy task. It requires a thorough analysis to find out which is a genuine HCG dropssupplement, which can give you the desired result.

In the market, you will find many products which claim to say that they contain HCG. However, a true weight loss drops supplement will have the HCG content accurately, rendering the aspired result.

There is a high probability of you toend up choosing a fake HCG drops being available in the market. However, these drops may not contain HCG at all. They might claim that they do. The best way to differentiate is, not to buy such oraldrop products, which are referred to as homeopathic. Non-homeopathic is actually the real HCG drops, which can offer you the desired and accurate results.

The best among all the available diet drops found in the market are, HCG Complex, HCG Triumph, and HCG 1234.

The way to differentiate between homeopathic and non-homeopathic HCG drops is quite simple. Homeopathic drops will be labeled as 1X, 2X, 4X, and the likes. This way, you will be able to make easily out which are the ones which should not be bought at all.

However, with the availability of Non-homeopathic HCG diet drops is almost null in the market, choosing the right product for yourself can still be challenging. But you can buy the HCG drops online easily.

We empathized the necessity of people, who are desperate about losing weight, and who have not been successful in doing so, despite having tried several weight loss methods. We decided to take up a research to find out which HCG drops products are best and have helped people lose weight, and for which product there has been an overwhelming response from people.

We decided we will come up with a detailed comparison and post them on the web so that people can make the informed decision before their purchase. Our product analysis isbased on reviews which they provided, with regard to the performance of the product in burning excess fat, and the success rate of losing pounds.

Oops! Did we confuse you by giving a lot of information about HCG drops? Dont worry!We will also offer you a comparative analysis for you to choose only what is best for you.After all, we want you to choose the most suitable HCG drops, which works very well for you.

Now, you understand that every product has an enticing benefit. But, we do not want to confuse our customers. Henceforth, we have come up with an HCG drops Comparison Analysis for people to choose the right product, which exactly matches their requirement of weight loss.

Follow this link:
Best HCG Drops Review: Top 3 Weight Loss Drops of 2017

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Fort Lauderdale Hormone Therapy Center – AAG Health

Doctor Certified Testosterone Replacement Therapy, HGH and Hormone Optimization Treatments in Fort Lauderdale, Pembroke Pines, Hollywood, and Aventura. With locations in Sunrise, Dania Beach, Pompano Beach, Las Olas, Wilton Manors. As well as Parkland, Coral Springs, Lauderhill, Plantation, and Davie. Fort Lauderdale Testosterone Replacement Therapy, HGH and Hormone OptimizationHormone Replacement and Testosterone Optimization Doctors in Fort Lauderdale

You can age optimally with medically supervised interventional wellness programs such as:

– Are you feeling as strong and vital as you did in your 20s or 30s? — Do you have the energy you once had? — The body? — The sex life? — Would you like to look and feel that way again? — You can with testosterone replacement, HGH therapy, and Hormone Optimization.

Hormones are a key part of the way your body functions. They are the chemical messengers secreted by the many glands of the endocrine system, and carried by the blood stream that stimulate and regulate most body processes.

Hormones are responsible for:

As you age all hormone levels decline, but the loss of testosterone and human growth hormone (HGH), have the greatest impact on your vitality, health, and sexual wellness.

The decline of testosterone that begins after you reach your peak testosterone levels in your 20s, in particular, effects your ability to perform in, and out of the bedroom!

Low testosterone in men, also referred to as Low-T, causes a number of symptoms we commonly attribute to aging. These include: thinning hair, weight gain, fatigue, loss of muscle tone, depression, and sexual wellness issues.

Bioidentical Hormone Therapy for men, and HGH Therapy can help with these symptoms and put you back on your path to peak performance at any age.

Hormone replacement therapy, or HRT, as the name implies, is all about renewing vitality by giving you back what age takes away.

Biologically speaking, hormones stimulate, facilitate, or regulate almost all of your bodily functions. Your body naturally produces and replaces hormones as needed. However, its ability to do so is not unlimited. As we age, our ability to produce hormones decreases. In particular are the hormones associated with sexual function and youthful vitality.

Dr. Richard Gaines, who supervises all of our Fort Lauderdale Testosterone Replacement Clinics, is a pioneer in the use of Bioidentical Testosterone Replacement Therapy for men. Dr. Gaines was one of the first physicians in Fort Lauderdale to recognize the condition of andropause also known as male menopause and how testosterone replacement can be used to treat it. In fact, he literally wrote the book, on optimal aging.

In very general terms, the symptoms of a hormone deficiency affect three areas: mental health, physical health and sexual health. In many cases you may be experiencing all or some of these symptoms, and you may be deficient in more than one hormone.

Typical symptoms of less-then-optimal hormone levels include:

At Fort Lauderdale HRT Therapy Centers we have helped hundreds of men just like you overcome the issues of decreased hormone with the best quality service and most competitive pricing on doctor certified Hormone Replacement (HRT) Therapy including Bioidentical Hormone Replacement (BHRT) for men, Testosterone replacement, and HGH replacement.

Contact us today to find our Hormone Lab Testing facilities throughout Fort Lauderdale and to see if any of our anti-aging and hormone optimization programs using Testosterone, HGH, Sermorelin, Thyroid replacement, and/or PRP for sexual wellness are right for you. If you live in Ft. Lauderdale, Hollywood,Hallandale, or in and around the City of Dania Beach, we have a hormone optimization specialist that is in your area.

At Fort Lauderdale Hormone Therapy Centers we are pioneers and experts in testosterone, hormone optimization, PRP, Platelet Rich Plasma, and HGH replacement therapy.

We customize your anti-aging and hormone optimization plans to your particular needs and lifestyle.Your testosterone, HGH (IGF-1) levels and otherhormone levels will be thoroughly tested for any imbalances or deficiencies. Low Testosterone, Low-T, andropause, male menopause as well as Human Growth Hormone Deficiency are legitimate medical health conditions that require proper diagnosis and treatment.

The Hormone Optimization medical specialists at Fort Lauderdale Optimal Aging Centers are certified professionals. Not all physicians or general practitioners have equal training or understanding of bio-identical hormone therapy (BHRT), or our expertise in diagnosing and developing treatment plans for men with low testosterone and/or HGH deficiencies. At our Testosterone Replacement and HGH Optimization centers our doctors have the knowledge and the know-how to help you age well through hormone optimization.

Fort Lauderdale Hormone Optimization Centers has testosterone replacement and optimal aging clinics in and around Fort Lauderdale, including: Hollywood, Aventura Dania Beach, and Davie. We have offices in Oakland Park, Lauderhill, Lauderdale-by-the Sea and Sunrise. Find us in Coral Springs,Pembroke Pines, Los Olas, Wilton Manors, and Plantation.

Testosterone and male enhancement, male enhancement and testosterone, testosterone and penis size, penis size and testosterone, Erectile dysfunction, erectile dysfunction cures, issues of erectile dysfunction, HGH, HRT therapy, hormone therapy for men, hormone replacement therapy, testosterone optimization, testosterone levels, HCG, HGH Diet, low testosterone, low testosterone symptoms, LowT, Low-T, low-T, penis enlargement, Priapus shot, andropause, male menopause, hormones for men, increase libido medically, medical treatments for Low-T, doctors who treat erectile dysfunction, Physicians specializing in Testosterone, medical treatments for testosterone, testosterones doctors, who fixes low testosterone, testosterone help, help with Low-T, medical male enhancement.

Common Fort Lauderdale Testosterone Searches: Fort Lauderdale Hormone Optimization, Testosterone Treatment FL, penis enlargement in Fort Lauderdale,Fort Lauderdale Male Clinic, Anti-aging in Fort Lauderdale, male enhancement Fort Lauderdale, Testosterone Therapies Fort Lauderdale, testosterone and penis size FL, penis size and testosterone FL, Erectile Dysfunction Clinic Fort Lauderdale, Mens Testosterone Clinic Fort Lauderdale, erectile dysfunction cures FL, HGH in Ft. Lauderdale, HRT therapy Miami, hormone therapy Hollywood, Hormones for men FL, Aventura, hormone replacement therapy, Ft. Lauderdale testosterone optimization, testosterone levels, HCG, HGH Diet Providers Ft. Lauderdale, low testosterone Ft. Lauderdale, testosterone symptoms FL, Low-T treatment Ft. Lauderdale, Ft. Lauderdale Low-T, penis enlargement Ft. Lauderdale, Ft. Lauderdale Priapus shot, hormones FL, male hormones FL.

When it comes to the production of testosterone, most men hit their peak around the age of 17. By the time you reach 80,your testosterone level will likely be about half of what it was when you were atyour peak. For some men, the decrease in production has little effect. But for many men, as you hit your 50s, 60s and older, you may actually start to feel the impact of the reduced level, experiencing low testosterone or Low-T.

Symptoms of Low-T include reduction of libido or sex drive, a feeling of reduced virility or vitality, changes in mood, erectile dysfunction, decreased energy, reduced muscle and bone mass, and memory issues.

If you are a man over 40, and you are experiencing any of these, you may have low testosterone. However, the only way to truly determine if you have an imbalance of one or more hormones related to your vitality, is with proper diagnosis and analysis.

All of our hormone optimization programs are overseen by Dr. Richard Gaines, a world-renowned leader in the field of hormone replacement therapy for men.

Call Fort Lauderdale HealthGains at (800) 325-1325 to find out if testosterone replacement, HGH treatments, or any of our other Hormone Optimization, or Hormone Replacement Therapies are right for you.

Read more:
Fort Lauderdale Hormone Therapy Center – AAG Health

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...